{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:20:20Z","timestamp":1768972820193,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["1067\/10"],"award-info":[{"award-number":["1067\/10"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/10109-5"],"award-info":[{"award-number":["2015\/10109-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/18125-0"],"award-info":[{"award-number":["2015\/18125-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12031-020-01588-7","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:02:26Z","timestamp":1590883346000},"page":"1574-1588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-0859","authenticated-orcid":false,"given":"Fabricio Ferreira","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3573-0164","authenticated-orcid":false,"given":"Elizabeth Suchi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-1033","authenticated-orcid":false,"given":"Marilia Cardoso","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-7502","authenticated-orcid":false,"given":"Paulo Henrique Ferreira","family":"Bertolucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,31]]},"reference":[{"key":"1588_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/JAD-2006-10404","volume":"10","author":"FAF Barbosa","year":"2006","unstructured":"Barbosa FAF, de Labio RW, Rigolin VOS, Minett T, Bertolucci PHF, Smith MAC, Pay\u00e3o SLM (2006) Apolipoprotein A-V gene polymorphism \u20131131T>C and Alzheimer\u2019s disease. J Alzheimers Dis 10:365\u2013369","journal-title":"J Alzheimers Dis"},{"key":"1588_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0004-282X1994000100001","volume":"52","author":"PHF Bertolucci","year":"1994","unstructured":"Bertolucci PHF, Brucki SMD, Campacci SR, Juliano Y (1994) The mini-mental state examination in an outpatient population: influence of literacy. Arq Neuropsiquiatr 52:1\u20137","journal-title":"Arq Neuropsiquiatr"},{"key":"1588_CR3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2217\/pgs-2016-0031","volume":"17","author":"R Cacabelos","year":"2016","unstructured":"Cacabelos R, Torrellas C, Tejido O, Carril JC (2016) Pharmacogenetic considerations in the treatment of Alzheimer\u2019s disease. Pharmacogenomics 17:1041\u20131074","journal-title":"Pharmacogenomics"},{"key":"1588_CR4","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1161\/01.STR.29.7.1401","volume":"29","author":"J Chapman","year":"1998","unstructured":"Chapman J, Wang N, Treves TA, Korczyn AD, Bornstein NM (1998) ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer\u2019s dementia. Stroke 29:1401\u20131404","journal-title":"Stroke"},{"key":"1588_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.brainres.2007.10.054","volume":"1187","author":"DW Chen","year":"2008","unstructured":"Chen DW, Yang JF, Tang Z, Dong XM, Feng XL, Yu S, Chan P (2008) Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE \u03b54 in Chinese. Brain Res 1187:52\u201357","journal-title":"Brain Res"},{"key":"1588_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.yexmp.2009.10.001","volume":"88","author":"ES Chen","year":"2010","unstructured":"Chen ES, Mazzotti DR, Furuya TK, Cendoroglo MS, Ramos LR, Araujo LQ, Burbano RR, Smith MAC (2010) Association of PPAR\u03b1 gene polymorphisms and lipid serum levels in a Brazilian elderly population. Exp Mol Pathol 88:197\u2013201","journal-title":"Exp Mol Pathol"},{"key":"1588_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/sj.emboj.7600938","volume":"25","author":"A Crameri","year":"2006","unstructured":"Crameri A, Biondi E, Kuehnle K, L\u00fctjohann D, Thelen KM, Perga S, Dotti CG, Nitsch RM, Ledesma MD, Mohajeri MH (2006) The role of seladin-1\/DHCR24 in cholesterol biosynthesis, APP processing and A\u03b2 generation in vivo. EMBO J 25:432\u2013443","journal-title":"EMBO J"},{"key":"1588_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00406-015-0663-4","volume":"266","author":"V De Luca","year":"2016","unstructured":"De Luca V, Orfei MD, Gaudenzi S, Caltagirone C, Spalletta G (2016) Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci 266:599\u2013606","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1588_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2013.10.015","volume":"336","author":"FF De Oliveira","year":"2014","unstructured":"De Oliveira FF, Bertolucci PHF, Chen ES, Smith MAC (2014a) Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer\u2019s disease. J Neurol Sci 336:103\u2013108","journal-title":"J Neurol Sci"},{"key":"1588_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/gps.4094","volume":"29","author":"FF De Oliveira","year":"2014","unstructured":"De Oliveira FF, Bertolucci PHF, Chen ES, Smith MC (2014b) Risk factors for age at onset of dementia due to Alzheimer\u2019s disease in a sample of patients with low mean schooling from S\u00e3o Paulo, Brazil. Int J Geriatr Psychiatry 29:1033\u20131039","journal-title":"Int J Geriatr Psychiatry"},{"key":"1588_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clineuro.2015.05.010","volume":"135","author":"FF De Oliveira","year":"2015","unstructured":"De Oliveira FF, Wajman JR, Bertolucci PHF, Chen ES, Smith MC (2015a) Correlations among cognitive and behavioural assessments in patients with dementia due to Alzheimer\u2019s disease. Clin Neurol Neurosurg 135:27\u201333","journal-title":"Clin Neurol Neurosurg"},{"key":"1588_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jns.2015.10.051","volume":"359","author":"FF De Oliveira","year":"2015","unstructured":"De Oliveira FF, Pivi GAK, Chen ES, Smith MC, Bertolucci PHF (2015b) Risk factors for cognitive and functional change in one year in patients with Alzheimer's disease dementia from S\u00e3o Paulo, Brazil. J Neurol Sci 359:127\u2013132","journal-title":"J Neurol Sci"},{"key":"1588_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2017.03.003","volume":"646","author":"FF De Oliveira","year":"2017","unstructured":"De Oliveira FF, Chen ES, Smith MC, Bertolucci PHF (2017) Longitudinal lipid profile variations and clinical change in Alzheimer\u2019s disease dementia. Neurosci Lett 646:36\u201342","journal-title":"Neurosci Lett"},{"key":"1588_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/ijmr.IJMR_1209_17","volume":"150","author":"FF De Oliveira","year":"2019","unstructured":"De Oliveira FF, Berretta JM, Almeida Junior GV, Almeida SS, Chen ES, Smith MC, Bertolucci PHF (2019) Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer\u2019s dementia. Indian J Med Res 150:261\u2013271","journal-title":"Indian J Med Res"},{"key":"1588_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00702-004-0273-1","volume":"112","author":"GP Eckert","year":"2005","unstructured":"Eckert GP, Wood WG, M\u00fcller WE (2005) Statins: drugs for Alzheimer\u2019s disease? J Neural Transm 112:1057\u20131071","journal-title":"J Neural Transm"},{"key":"1588_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2004.09.001","volume":"26","author":"RK Gopalraj","year":"2005","unstructured":"Gopalraj RK, Zhu H, Kelly JF, Mendiondo M, Pulliam JF, Bennett DA, Estus S (2005) Genetic association of low density lipoprotein receptor and Alzheimer\u2019s disease. Neurobiol Aging 26:1\u20137","journal-title":"Neurobiol Aging"},{"key":"1588_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneur.61.1.59","volume":"61","author":"M Grundman","year":"2004","unstructured":"Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR Jr, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61:59\u201366","journal-title":"Arch Neurol"},{"key":"1588_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CNB, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110:227\u2013239","journal-title":"Circulation"},{"key":"1588_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Lee CYD, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE (2008) ApoE promotes the proteolytic degradation of A\u03b2. Neuron 58:681\u2013693","journal-title":"Neuron"},{"key":"1588_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2190\/UURL-2RYU-WRYD-EY3K","volume":"6","author":"S Katz","year":"1976","unstructured":"Katz S, Akpom CA (1976) A measure of primary socio-biological functions. Int J Health Serv 6:493\u2013508","journal-title":"Int J Health Serv"},{"key":"1588_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3233\/JAD-180288","volume":"64","author":"SC Larsson","year":"2018","unstructured":"Larsson SC, Markus HS (2018) Does treating vascular risk factors prevent dementia and Alzheimer\u2019s disease? A systematic review and meta-analysis. J Alzheimers Dis 64:657\u2013668","journal-title":"J Alzheimers Dis"},{"key":"1588_CR22","first-page":"789","volume":"24","author":"MP Lawton","year":"1988","unstructured":"Lawton MP (1988) Instrumental Activities of Daily Living (IADL) Scale: self-reported version. Psychopharmacol Bull 24:789\u2013791","journal-title":"Psychopharmacol Bull"},{"key":"1588_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12031-015-0666-7","volume":"58","author":"V Leduc","year":"2016","unstructured":"Leduc V, Th\u00e9roux L, Dea D, Dufour R, Poirier J (2016) Effects of rs3846662 variants on HMGCR mRNA and protein levels and on markers of Alzheimer\u2019s disease pathology. J Mol Neurosci 58:109\u2013119","journal-title":"J Mol Neurosci"},{"key":"1588_CR24","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CYD Lee","year":"2010","unstructured":"Lee CYD, Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm 117:949\u2013960","journal-title":"J Neural Transm"},{"key":"1588_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.20517\/2347-8659.2018.26","volume":"5","author":"M Leon","year":"2018","unstructured":"Leon M, Sawmiller D, Giunta B, Tan J (2018) Therapeutic approach targeting apolipoprotein E binding region and low-density lipoprotein receptor for Alzheimer\u2019s disease. Neuroimmunol Neuroinflammation 5:30","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"1588_CR26","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1212\/WNL.0b013e31826e9ae6","volume":"79","author":"YY Lim","year":"2012","unstructured":"Lim YY, Ellis KA, Pietrzak RH, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P (2012) Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology 79:1645\u20131652","journal-title":"Neurology"},{"key":"1588_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/WAD.0000000000000205","volume":"31","author":"APV Lima","year":"2017","unstructured":"Lima APV, Castilhos R, Chaves MLF (2017) The use of the clinical dementia rating scale sum of boxes scores in detecting and staging cognitive impairment\/dementia in Brazilian patients with low educational attainment. Alzheimer Dis Assoc Disord 31:322\u2013327","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1588_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","volume":"190","author":"R Loera-Valencia","year":"2019","unstructured":"Loera-Valencia R, Goikolea J, Parrado-Fernandez C, Merino-Serrais P, Maioli S (2019) Alterations in cholesterol metabolism as a risk factor for developing Alzheimer\u2019s disease: potential novel targets for treatment. J Steroid Biochem Mol Biol 190:104\u2013114","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1588_CR29","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/phar.1981","volume":"37","author":"WD Maxwell","year":"2017","unstructured":"Maxwell WD, Ramsey LB, Johnson SG, Moore KG, Shtutman M, Schoonover JH, Kawaguchi-Suzuki M (2017) Impact of pharmacogenetics on efficacy and safety of statin therapy for dyslipidemia. Pharmacotherapy 37:1172\u20131190","journal-title":"Pharmacotherapy"},{"key":"1588_CR30","first-page":"CD007514","volume":"7","author":"B McGuiness","year":"2014","unstructured":"McGuiness B, Craig D, Bullock R, Malouf R, Passmore P (2014) Statins for the treatment of dementia (review). Cochrane Database Syst Rev 7:CD007514","journal-title":"Cochrane Database Syst Rev"},{"key":"1588_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JAD-130326","volume":"37","author":"K Morgen","year":"2013","unstructured":"Morgen K, Fr\u00f6lich L, Tost H, Plichta MM, K\u00f6lsch H, Rakebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, H\u00fcll M, Gertz HJ, Schr\u00f6der J, Hampel H, Teipel SJ, Pantel J, Heuser I, Wiltfang J, R\u00fcther E, Kornhuber J, Maier W, Meyer-Lindenberg A (2013) APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer\u2019s disease. J Alzheimers Dis 37:389\u2013401","journal-title":"J Alzheimers Dis"},{"key":"1588_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1590\/1516-4446-2016-1991","volume":"39","author":"FF Oliveira","year":"2017","unstructured":"Oliveira FF, Chen ES, Smith MC, Bertolucci PH (2017) Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer\u2019s disease dementia. Rev Bras Psiquiatr 39:95\u2013103","journal-title":"Rev Bras Psiquiatr"},{"key":"1588_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/1533317512452034","volume":"27","author":"SN Ozudogru","year":"2012","unstructured":"Ozudogru SN, Lippa CF (2012) Disease modifying drugs targeting \u03b2-amyloid. Am J Alzheimers Dis Other Dement 27:296\u2013300","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"1588_CR34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3961\/jpmph.2009.42.6.371","volume":"42","author":"SK Park","year":"2009","unstructured":"Park SK, Choi JY (2009) Risk assessment and pharmacogenetics in molecular and genomic epidemiology. J Prev Med Public Health 42:371\u2013376","journal-title":"J Prev Med Public Health"},{"key":"1588_CR35","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/joim.12838","volume":"284","author":"B Petek","year":"2018","unstructured":"Petek B, Villa-Lopez M, Loera-Valencia R, Gerenu G, Winblad B, Kramberger MG, Ismail MAM, Eriksdotter M, Garcia-Ptacek S (2018) Connecting the brain cholesterol and renin-angiotensin systems: potential role of statins and RAS-modifying medications in dementia. J Intern Med 284:620\u2013642","journal-title":"J Intern Med"},{"key":"1588_CR36","first-page":"147","volume":"24","author":"J Poirier","year":"1999","unstructured":"Poirier J (1999) Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer\u2019s disease. J Psychiatry Neurosci 24:147\u2013153","journal-title":"J Psychiatry Neurosci"},{"key":"1588_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362:329\u2013344","journal-title":"N Engl J Med"},{"key":"1588_CR38","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/archneurol.2010.88","volume":"67","author":"AD Roses","year":"2010","unstructured":"Roses AD (2010) An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. Arch Neurol 67:536\u2013541","journal-title":"Arch Neurol"},{"key":"1588_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","volume":"77","author":"M Sano","year":"2011","unstructured":"Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS (2011) A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology 77:556\u2013563","journal-title":"Neurology"},{"key":"1588_CR40","doi-asserted-by":"publisher","first-page":"S03","DOI":"10.1590\/S1516-44461999000600003","volume":"21","author":"MAC Smith","year":"1999","unstructured":"Smith MAC (1999) Doen\u00e7a de Alzheimer. Rev Bras Psiquiatr 21:S03\u2013S07","journal-title":"Rev Bras Psiquiatr"},{"key":"1588_CR41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archneur.62.5.753","volume":"62","author":"DL Sparks","year":"2005","unstructured":"Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C (2005) Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol 62:753\u2013757","journal-title":"Arch Neurol"},{"key":"1588_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman ER, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:280\u2013292","journal-title":"Alzheimers Dement"},{"key":"1588_CR43","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1590\/S0102-311X2004000200004","volume":"20","author":"A Taub","year":"2004","unstructured":"Taub A, Andreoli SB, Bertolucci PHF (2004) Dementia caregiver burden: reliability of the Brazilian version of the Zarit caregiver burden interview. Cad Saude Publica 20:372\u2013376","journal-title":"Cad Saude Publica"},{"key":"1588_CR44","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nm1287","volume":"11","author":"Z Wu","year":"2005","unstructured":"Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kanagala S, Rubio A, Sagare A, Liu D, Li F, Armstrong D, Gasiewicz T, Zidovetzki R, Song X, Hofman F, Zlokovic BV (2005) Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med 11:959\u2013965","journal-title":"Nat Med"},{"key":"1588_CR45","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/glia.22974","volume":"64","author":"N Yamamoto","year":"2016","unstructured":"Yamamoto N, Fujii Y, Kasahara R, Tanida M, Ohora K, Ono Y, Suzuki K, Sobue K (2016) Simvastatin and atorvastatin facilitates amyloid \u03b2-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK\/Erk1\/2 pathways. Glia 64:952\u2013962","journal-title":"Glia"},{"key":"1588_CR46","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1007\/s11033-014-3313-4","volume":"41","author":"HC Yan","year":"2014","unstructured":"Yan HC, Wang W, Dou CW, Tian FM, Qi ST (2014) Relationships of LDLR genetic polymorphisms with cerebral infarction: a meta-analysis. Mol Biol Rep 41:4425\u20134434","journal-title":"Mol Biol Rep"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01588-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01588-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01588-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T18:26:17Z","timestamp":1722968777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01588-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,31]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01588-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,31]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures were in accordance with the ethical standards of the Ethics Committee of <i>Hospital S\u00e3o Paulo<\/i>, Federal University of S\u00e3o Paulo\u2013UNIFESP, according to the research project 1067\/10 (CAAE 0540.0.174.000-10), and followed The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. All invited patients and their legal representatives agreed to participate on the research and signed the Informed Consent Form before the evaluation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}